Shiro Iwagami
Papers
1
Total Citations
2
H-Index
1
About
Shiro Iwagami is a leading surgical oncologist whose research focuses on advanced gastric cancer, particularly the role of conversion surgery in treating stage IV disease with distant metastases. His most-cited work, a 2024 study on achieving a complete pathological response to S-1 plus oxaliplatin therapy in a patient with multiple liver metastases, demonstrates his commitment to pushing the boundaries of curative treatment for previously inoperable cases. This landmark paper, with 2 citations, highlights his expertise in integrating aggressive chemotherapy with surgical intervention to improve outcomes in the most challenging scenarios. Iwagami’s contributions are pivotal in redefining the potential for long-term survival in metastatic gastric cancer, offering new hope through personalized, multimodal approaches. His research underscores the importance of pathological response as a prognostic marker and surgical guide, influencing clinical protocols in Japan and beyond. As a clinician-scientist, Iwagami continues to bridge the gap between chemotherapy and surgery, advancing the field of oncologic gastrectomy with a focus on patient-centered, evidence-based care.
Research Focus
Key Achievements
Top Papers
- 1